YALE UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
Imaging the Neuroimmune System in PTSD
Phase 1
Completed
- Conditions
- Post Traumatic Stress Disorder
- Interventions
- Drug: Lipopolysaccharide
- First Posted Date
- 2020-01-22
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Yale University
- Target Recruit Count
- 80
- Registration Number
- NCT04236986
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Neuroimmune Response to Lipopolysaccharide
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Biological: Lipopolysaccharide
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2022-07-19
- Lead Sponsor
- Yale University
- Target Recruit Count
- 27
- Registration Number
- NCT04233593
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Voiding Diary Video
Not Applicable
Completed
- Conditions
- Urinary Incontinence
- Interventions
- Other: 5-minute educational videoOther: Usual Care
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2022-06-10
- Lead Sponsor
- Yale University
- Target Recruit Count
- 86
- Registration Number
- NCT04233645
- Locations
- 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States
Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana Products
Phase 1
Completed
- Conditions
- Pain
- Interventions
- Drug: Active CBD/THC Dose 2Drug: matched placebo comparatorDrug: Active CBD/THC Dose 1
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Yale University
- Target Recruit Count
- 24
- Registration Number
- NCT04226690
- Locations
- 🇺🇸
The Yale Stress Center: Yale University, New Haven, Connecticut, United States
Emergency Department-Initiated Buprenorphine Validation Network Trial
Phase 2
Completed
- Conditions
- Opioid-use Disorder
- Interventions
- Drug: CAM2038Drug: Buprenorphine Sublingual Product
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Yale University
- Target Recruit Count
- 2000
- Registration Number
- NCT04225598
- Locations
- 🇺🇸
Highland Hospital, Oakland, California, United States
🇺🇸San Leandro Hospital, San Leandro, California, United States
🇺🇸Yale New Haven Health (Yale New Haven Hospital), New Haven, Connecticut, United States
Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma
Early Phase 1
Withdrawn
- Conditions
- Malignant Melanoma
- Interventions
- Drug: tremelimumab/durvalumab, ipilimumab/nivolumab and nivolumab monotherapy
- First Posted Date
- 2020-01-10
- Last Posted Date
- 2021-11-22
- Lead Sponsor
- Yale University
- Registration Number
- NCT04223648
Repeat Dosing of Psilocybin in Migraine Headache
- First Posted Date
- 2020-01-06
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- Yale University
- Target Recruit Count
- 18
- Registration Number
- NCT04218539
- Locations
- 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States
CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes
Not Applicable
Recruiting
- Conditions
- Gestational DiabetesMaternal Complication of Pregnancy
- Interventions
- Other: Routine CareDevice: Continuous Glucose Monitor
- First Posted Date
- 2020-01-06
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Yale University
- Target Recruit Count
- 80
- Registration Number
- NCT04219085
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Blood PREssure Augmentation in Large-vessel Occlusion Stroke Study
Early Phase 1
- Conditions
- Blood PressureIschemic Stroke
- Interventions
- First Posted Date
- 2020-01-06
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- Yale University
- Target Recruit Count
- 40
- Registration Number
- NCT04218773
- Locations
- 🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States
Models of Auditory Hallucination
Not Applicable
Terminated
- Conditions
- Schizo Affective DisorderAuditory HallucinationSchizophrenia
- Interventions
- Device: Transcranial Magnetic Stimulation (TMS)
- First Posted Date
- 2019-12-24
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Yale University
- Target Recruit Count
- 1
- Registration Number
- NCT04210557
- Locations
- 🇺🇸
Connecticut Mental Health Center (CMHC), New Haven, Connecticut, United States
© Copyright 2025. All Rights Reserved by MedPath